Strs Ohio grew its holdings in The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 1.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,844 shares of the medical device company’s stock after purchasing an additional 65 shares during the quarter. Strs Ohio’s holdings in Cooper Companies were worth $1,014,000 as of its most recent filing with the SEC.
A number of other institutional investors have also added to or reduced their stakes in COO. Trust Co. of Vermont bought a new position in Cooper Companies during the second quarter worth about $27,000. Parkside Financial Bank & Trust increased its holdings in shares of Cooper Companies by 65.5% in the second quarter. Parkside Financial Bank & Trust now owns 96 shares of the medical device company’s stock valued at $30,000 after purchasing an additional 38 shares in the last quarter. Clear Street Markets LLC grew its holdings in Cooper Companies by 410.0% during the 2nd quarter. Clear Street Markets LLC now owns 102 shares of the medical device company’s stock worth $32,000 after acquiring an additional 82 shares during the period. Ellevest Inc. grew its holdings in Cooper Companies by 82.4% during the 2nd quarter. Ellevest Inc. now owns 124 shares of the medical device company’s stock worth $39,000 after acquiring an additional 56 shares during the period. Finally, NuWave Investment Management LLC acquired a new stake in Cooper Companies during the 2nd quarter worth $54,000. 96.78% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several brokerages have recently issued reports on COO. Jefferies Financial Group lowered shares of Cooper Companies from a “buy” rating to a “hold” rating and decreased their price target for the company from $400.00 to $295.00 in a report on Tuesday, October 11th. Citigroup boosted their price target on shares of Cooper Companies from $348.00 to $368.00 and gave the stock a “buy” rating in a research report on Monday, December 12th. Piper Sandler boosted their price target on shares of Cooper Companies from $350.00 to $375.00 and gave the stock an “overweight” rating in a research report on Wednesday. Robert W. Baird dropped their target price on shares of Cooper Companies from $370.00 to $355.00 and set an “outperform” rating on the stock in a report on Friday, December 9th. Finally, StockNews.com began coverage on shares of Cooper Companies in a research note on Wednesday, October 12th. They issued a “hold” rating on the stock. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $378.10.
Cooper Companies Trading Up 0.3 %
Cooper Companies (NYSE:COO – Get Rating) last released its quarterly earnings results on Thursday, December 8th. The medical device company reported $2.75 earnings per share for the quarter, missing analysts’ consensus estimates of $3.11 by ($0.36). The firm had revenue of $848.10 million for the quarter, compared to the consensus estimate of $838.88 million. Cooper Companies had a net margin of 11.66% and a return on equity of 8.76%. The firm’s revenue for the quarter was up 11.7% on a year-over-year basis. During the same period in the previous year, the business earned $3.28 earnings per share. Analysts expect that The Cooper Companies, Inc. will post 12.47 EPS for the current fiscal year.
Cooper Companies Dividend Announcement
The business also recently disclosed a Semi-Annual dividend, which will be paid on Friday, February 10th. Shareholders of record on Monday, January 23rd will be given a $0.03 dividend. The ex-dividend date is Friday, January 20th. Cooper Companies’s dividend payout ratio is 0.77%.
Insiders Place Their Bets
In other Cooper Companies news, Director Jody S. Lindell sold 1,000 shares of Cooper Companies stock in a transaction dated Friday, January 6th. The shares were sold at an average price of $344.30, for a total value of $344,300.00. Following the sale, the director now owns 13,543 shares of the company’s stock, valued at $4,662,854.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.70% of the company’s stock.
Cooper Companies Company Profile
The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.
- Get a free copy of the StockNews.com research report on Cooper Companies (COO)
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here’s Why
- Carvana Stock Rally, Here’s What You Need to Know
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.